Publication | Closed Access

Idiopathic Parkinson’s Disease at the End of Life: A Retrospective Evaluation of Symptom Prevalence, Pharmacological Symptom Management and Transdermal Rotigotine Dosing

Neurodegenerative DiseasesSymptom PrevalenceParkinson DiseasePharmacologyNeurologyTransdermal Rotigotine DosingMedicineIdiopathic Parkinson ’Movement Disorders